Dupilumab significantly improves sleep outcomes in adult patients with atopic dermatitis: results from five randomized clinical trials

J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e130-e133. doi: 10.1111/jdv.16865. Epub 2020 Sep 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Randomized Controlled Trials as Topic
  • Sleep

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab